Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.19B |
| 2 |
GE Vernova
GEV
|
+$1.16B |
| 3 |
Meta Platforms (Facebook)
META
|
+$501M |
| 4 |
Palantir
PLTR
|
+$451M |
| 5 |
DoorDash
DASH
|
+$411M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.22B |
| 2 |
Ascendis Pharma A/S
ASND
|
+$866M |
| 3 |
Applovin
APP
|
+$690M |
| 4 |
DAY
Dayforce
DAY
|
+$576M |
| 5 |
Workday
WDAY
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.5% |
| 2 | Healthcare | 20.49% |
| 3 | Industrials | 11.17% |
| 4 | Consumer Discretionary | 9.27% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Dynatrace
DT
$12.1B
| $187M | 0.09% |
5,062,820
+155,793
| +3% | +$5.95M |
|
202
Edgewise Therapeutics
EWTX
$4.34B
| $186M | 0.09% |
5,915,556
+1,348,706
| +30% | +$38.9M |
|
203
Veralto
VLTO
$22.6B
| $185M | 0.09% |
2,095,393
+69,578
| +3% | +$6.61M |
|
204
Descartes Systems
DSGX
$5.84B
| $184M | 0.09% |
2,574,468
+100,937
| +4% | +$7.45M |
|
205
Ares Management
ARES
$28.2B
| $180M | 0.09% |
1,653,078
+503,688
| +44% | +$66.8M |
|
206
Welltower
WELL
$176B
| $178M | 0.08% |
898,586
+209,618
| +30% | +$41.4M |
|
207
Vanguard S&P 500 ETF
VOO
$973B
| $177M | 0.08% |
296,591
-180,202
| -38% | -$113M |
|
208
MACOM Technology Solutions
MTSI
$20.7B
| $174M | 0.08% |
784,118
+105,032
| +15% | +$23.4M |
|
209
AXIS Capital
AXS
$8.6B
| $174M | 0.08% |
1,710,902
+21,001
| +1% | +$2.16M |
|
210
Caesars Entertainment
CZR
$6.1B
| $173M | 0.08% |
6,529,700
+355,760
| +6% | +$8.46M |
|
211
Jack Henry & Associates
JKHY
$10.7B
| $170M | 0.08% |
1,078,398
+1,070,376
| +13,343% | +$183M |
|
212
Core & Main
CNM
$8.2B
| $167M | 0.08% |
3,377,281
-1,246,446
| -27% | -$67.1M |
|
213
DexCom
DXCM
$27.6B
| $166M | 0.08% |
2,644,539
+645,534
| +32% | +$45M |
|
214
Southern Company
SO
$109B
| $165M | 0.08% |
1,713,552
+1,636,051
| +2,111% | +$151M |
|
215
Sensient Technologies
SXT
$5.17B
| $165M | 0.08% |
1,905,920
-178,391
| -9% | -$16.7M |
|
216
Nextpower Inc
NXT
$15.3B
| $164M | 0.08% |
1,362,466
+780,958
| +134% | +$86.5M |
|
217
Crinetics Pharmaceuticals
CRNX
$8.87B
| $164M | 0.08% |
4,520,251
+79,560
| +2% | +$3.55M |
|
218
Flutter Entertainment
FLUT
$17.6B
| $163M | 0.08% |
1,601,605
+20,810
| +1% | +$3M |
|
219
Jabil
JBL
$33B
| $163M | 0.08% |
614,279
+128,782
| +27% | +$32.4M |
|
220
W.R. Berkley
WRB
$27.9B
| $163M | 0.08% |
2,457,890
-1,099,917
| -31% | -$75.8M |
|
221
Prologis
PLD
$137B
| $162M | 0.08% |
1,224,573
-34,796
| -3% | -$4.65M |
|
222
Regeneron Pharmaceuticals
REGN
$69.7B
| $162M | 0.08% |
209,248
+3,576
| +2% | +$2.74M |
|
223
Surgery Partners
SGRY
$2.11B
| $161M | 0.08% |
13,540,385
+2,401
| +0% | +$34.5K |
|
224
Comfort Systems
FIX
$62.5B
| $159M | 0.08% |
115,378
+16,451
| +17% | +$20.9M |
|
225
iShares Core International Aggregate Bond Fund
IAGG
$10.6B
| $158M | 0.08% |
3,157,170
+710,944
| +29% | +$35.7M |
|
Similar funds
Janus Henderson Group's Q1 2026 Portfolio in Review
As of Q1 2026, Janus Henderson Group held 2,488 positions worth $209B, down 6.2% from $223B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Janus Henderson Group's Q1 2026 filing shows 82 new, 739 increased, 627 reduced and 81 closed positions. Its largest new stake was Forgent Power Solutions: 7,769,612 shares worth $227M. The largest sale was Microsoft, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2026 buy was Forgent Power Solutions: 7,769,612 shares worth $227M.
- Janus Henderson Group added most to AstraZeneca in Q1 2026, an estimated $2.19B increase.
- Janus Henderson Group's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Ascendis Pharma A/S in Q1 2026, selling an estimated $866M.
- Janus Henderson Group's ten largest holdings make up 30% of its $209B portfolio in Q1 2026.
- Janus Henderson Group opened 82 new positions and closed 81 in Q1 2026.
- Janus Henderson Group's portfolio value fell 6.2% quarter-over-quarter to $209B.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.